COVID-19 my database [updated 03 August 2021]

All my news about Covid-19 in one place [from the newest to the oldest]

(title, date of publication and anchor to the news).

1. Association of Remdesivir Treatment With Survival and Length of Hospital Stay [03 August 2021] https://www.dhirubhai.net/posts/marcinkopka_remdesivir-survival-and-length-of-hospital-activity-6828444821057802240-MmhY
2. The cases of atypical migraine during Covid19 infection [18 June 2021] https://www.dhirubhai.net/posts/marcinkopka_the-unusual-course-of-a-migraine-attack-during-activity-6811769154002063360-ZFcQ
3. Longterm health consequences of patients with COVID19 [16 June 2021] https://www.dhirubhai.net/posts/marcinkopka_6-month-consequences-of-covid-19-in-patients-activity-6811045346219753472-9lXV
4. Sotrovimab for the treatment of mild-to-moderate Covid19 in adults [04 June 2021] https://www.dhirubhai.net/posts/marcinkopka_coronavirus-covid-19-update-fda-authorizes-activity-6805242734308315136-6SBu
5. Ad26COV2S vaccine for the prevention of Covid19 in adults [23 April 2021]. https://www.dhirubhai.net/posts/marcinkopka_safety-and-efficacy-of-single-dose-ad26cov2-activity-6791088343582093312-GC_l
6. Early initiation of prophylactic anticoagulation in Covid-19 patients [21 April 2021] https://www.dhirubhai.net/posts/marcinkopka_early-initiation-of-prophylactic-anticoagulation-activity-6790760803319508992-_7-D
7. Inhaled budesonide in the treatment of early COVID-19 [20 April 2021] https://www.dhirubhai.net/posts/marcinkopka_inhaled-budesonide-in-the-treatment-of-early-activity-6790398422806519808-_SEN
8. Persistent neurologic symptoms in non-hospitalized Covid-19 patients [19 April 2021] https://www.dhirubhai.net/posts/marcinkopka_persistent-neurologic-symptoms-and-cognitive-activity-6789991566053318657-LR1t
9. Body temperature and mortality in COVID-19 patients [17 April 2021] https://www.dhirubhai.net/posts/marcinkopka_body-temperature-correlates-with-mortality-activity-6789144800240173056-vSLS
10. Convalescent Plasma in Covid-19 Severe Pneumonia [05 March 2021] https://www.dhirubhai.net/posts/marcinkopka_a-randomized-trial-of-convalescent-plasma-activity-6773336565419716609-s0It
11. The results of the RECOVERY?trial [03 March 2021]?https://www.dhirubhai.net/posts/marcinkopka_dexamethasone-in-hospitalized-patients-with-activity-6772629634531028992-lfaP
12. Psychiatric disorders and mortality among patients with COVID-19 [22 February 2021] https://www.dhirubhai.net/posts/marcinkopka_association-of-psychiatric-disorders-with-activity-6769707143508606976-4jcB
13. Cerebral venous trombosis and SARS-CoV-2 infection [09 February 2021] https://www.dhirubhai.net/posts/marcinkopka_cerebral-venous-thrombosis-and-severe-acute-activity-6765040839078113280-OsIQ
14. Efficacy and Safety of the?mRNA1273 SARSCoV2 vaccine [08 February 2021] https://www.dhirubhai.net/posts/marcinkopka_efficacy-and-safety-of-the-mrna-1273-sars-cov-activity-6764653795394809857-I2G5
15. SARS-CoV-2 nucleic acid screening programme in Wuhan [26 January 2021] https://www.dhirubhai.net/posts/marcinkopka_post-lockdown-sars-cov-2-nucleic-acid-screening-activity-6759973424631742465-xRB3
16. Risk of reinfection after SARS-Cov-2 infection [24 January 2021] https://www.dhirubhai.net/posts/marcinkopka_siren-sarscov2-activity-6759044505342668800-fjb5
17. Risk factors for severe?Covid 19 in patients with MS [23 January 2021] https://www.dhirubhai.net/posts/marcinkopka_clinical-characteristics-and-outcomes-in-activity-6758673290354585600-mSU9
18. Short-term efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine [3 January 2021] https://www.dhirubhai.net/posts/marcinkopka_cove-mrna1273-vaccine-activity-6751439035849334784-puNS
19. The results of WHO Solidarity trial?[29 December 2020] https://www.dhirubhai.net/posts/marcinkopka_who-solidarity-remdesivir-activity-6749833358945128448-QRiX
20. Bamlanivimab for treatment of recently diagnosed patients with mild to moderate COVID19?[18 December 2020] https://www.dhirubhai.net/posts/marcinkopka_an-eua-for-bamlanivimaba-monoclonal-antibody-activity-6745471696850993152-zaOg
21. Safety and #efficacy of BNT162b2 vaccine in preventing Covid19 [16 December 2020] https://www.dhirubhai.net/posts/marcinkopka_safety-and-efficacy-of-the-bnt162b2-mrna-activity-6744388853165015041-ydSQ
22. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine [29 November 2020] https://www.dhirubhai.net/posts/marcinkopka_safety-and-immunogenicity-of-chadox1-ncov-activity-6738953661080240128-3uss
23. Physical distance, face masks, and eye protection are useful in reduction of SARS-Cov-2 virus transmission [28 October 2020] https://www.dhirubhai.net/posts/marcinkopka_physical-distancing-face-masks-and-eye-activity-6727341288758292480-22lh
24. SARS-CoV-2 infection as a risk factor for early pregnancy loss [20 October 2020] https://www.dhirubhai.net/posts/marcinkopka_covid-19-and-first-trimester-spontaneous-activity-6724806572180086784-Evof
25. Remdesivir for the Treatment of Covid-19 [18 October 2020] https://www.dhirubhai.net/posts/marcinkopka_actt-efficacy-safety-activity-6723523186501173248-kn94
26. Patients with mild or moderate COVID-19 unlikely to be infectious after day 10 of symptom onset [16 October 2020] https://www.dhirubhai.net/posts/marcinkopka_the-duration-of-infectiousness-of-individuals-activity-6722978440380772352-HkQg
27. COVID-19 in patients with multiple sclerosis treated with teriflunomide [28 September 2020] https://www.dhirubhai.net/posts/marcinkopka_covid-19-in-teriflunomide-treated-patients-activity-6716471119718731776-hJ0y
28. The prevalence of SARS‐CoV‐2 infection in health professionals in maternity units [30 August 2020] https://www.dhirubhai.net/posts/marcinkopka_a-crosssectional-study-of-immune-seroconversion-activity-6705814026930196480-iz_f
29. The efficacy and safety of methylprednisolone in Covid19 [19 August 2020] https://www.dhirubhai.net/posts/marcinkopka_clinical-outcomes-associated-with-methylprednisolone-activity-6701599707514372097-qWdw
30. Myasthenia Gravis Associated With SARS-CoV-2 Infection [17 August 2020] https://www.dhirubhai.net/posts/marcinkopka_myasthenia-gravis-associated-with-sars-cov-activity-6700874175327875072-oaIc
31. Fasting blood glucose at admission and mortality in patients with COVID-19 [28 July 2020] https://www.dhirubhai.net/posts/marcinkopka_fasting-blood-glucose-at-admission-is-an-activity-6693856192567005185-cy_f
32. Obesity is a strong risk factor for respiratory failure in COVID-19 patients [27 July 2020] https://www.dhirubhai.net/posts/marcinkopka_how-important-is-obesity-as-a-risk-factor-activity-6693445295008731136-qIME
33. The results of phase 1 study of candidate vaccine mRNA-1273 against SARS-CoV-2 [17 July 2020] https://www.dhirubhai.net/posts/marcinkopka_immunogenicity-of-a-candidate-sars-cov-2-activity-6689800267459825664-bIts
34. Headache in patients with Covid19 may predict the clinical evolution of the disease?https://www.dhirubhai.net/posts/marcinkopka_headaches-covid19-activity-6686541940122550272-MdZb [8 July 2020]
35. Dexamethasone reduces death by up to one third in hospitalised patients with severe COVID-19 [19 June 2020] https://www.dhirubhai.net/posts/marcinkopka_low-cost-dexamethasone-reduces-death-by-up-activity-6679665961890525184-bPCU
36. Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children?[15 June 2020] https://www.dhirubhai.net/posts/marcinkopka_effect-of-gastrointestinal-symptoms-in-patients-activity-6678200684124352512-jE22
37. Impact of sex on mortality in patients with COVID-19 [10 June 2020] https://www.dhirubhai.net/posts/marcinkopka_impact-of-sex-and-gender-on-covid-19-outcomes-activity-6676395847514648576-P5Bp
38. Subacute Thyroiditis in patient after Sars-COV-2 Infection?[9 June 2020] https://www.dhirubhai.net/posts/marcinkopka_subacute-thyroiditis-after-sars-cov-2-infection-activity-6676037917539872769-tXJt
39. Focal status epilepticus in patient with COVID-19 [8 June 2020] https://www.dhirubhai.net/posts/marcinkopka_focal-status-epilepticus-as-unique-clinical-activity-6675678777231601664-KRFr
40. Hydroxychloroquine ineffective in the treatment of COVID-19 [4 June 2020] https://www.dhirubhai.net/posts/marcinkopka_hydroxychloroquine-or-chloroquine-with-or-activity-6674218565647831041-los_(this study was retracted https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31324-6/fulltext)
41. COVID-19 and Asthma [3 June 2020] https://www.dhirubhai.net/posts/marcinkopka_chronic-diseases-journal-activity-6673853624461922304-ZPUg
42. Brain MRI Findings in Patients with COVID-19 Infection [2 June 2020] https://www.dhirubhai.net/posts/marcinkopka_brain-mri-findings-in-patients-in-the-intensive-activity-6673485562059599872-uM3V
43. Risk factors in patients with cancer and Covid-19 [1 June 2020] https://www.dhirubhai.net/posts/marcinkopka_clinical-characteristics-and-risk-factors-activity-6673137380322623488-X7wV
44. Acute heart failure in multisystem inflammatory syndrome in children [22 May 2020] https://www.dhirubhai.net/posts/marcinkopka_acute-heart-failure-in-multisystem-inflammatory-activity-6669517634918338560-dm-4
45. Use of Prone Positioning in Nonintubated Patients With COVID-19 [21 May 2020] https://www.dhirubhai.net/posts/marcinkopka_prone-positioning-in-nonintubated-patients-activity-6669140093040779264-brMn
46. New onset acute symptomatic seizure in Covid-19 [20 May 2020] https://www.dhirubhai.net/posts/marcinkopka_new-onset-acute-symptomatic-seizure-and-risk-activity-6668778819845001216-CKyI
47. COPD and Smoking in patients with COVID-19 [19 May 2020] https://www.dhirubhai.net/posts/marcinkopka_prevalence-severity-and-mortality-associated-activity-6668418342782685185-wR5H
48. Kidney injury in patients with Covid-19 [18 May 2020] https://www.dhirubhai.net/posts/marcinkopka_acute-kidney-injury-in-patients-hospitalized-activity-6668060967579987968-RiWs
49. COVID-19 and Kawasaki Disease [15 May 2020] https://www.dhirubhai.net/posts/marcinkopka_covid-19-and-kawasaki-disease-novel-virus-activity-6666969051593486336-nZNS
50. The association between mean levels of vitamin D and mortality in COVID-19 [14 May 2020] https://www.dhirubhai.net/posts/marcinkopka_the-role-of-vitamin-d-in-the-prevention-of-activity-6666604955278823424-9FV_
51. Olfactory and gustatory dysfunction is very common in COVID-19 patients [13 May 2020] https://www.dhirubhai.net/posts/marcinkopka_olfactory-and-gustatory-dysfunction-in-coronavirus-activity-6666247652398645250-2yl8
52. Tocilizumab for the treatment of severe Covid-19 [12 May 2020] https://www.dhirubhai.net/posts/marcinkopka_tocilizumab-for-the-treatment-of-severe-coronavirus-activity-6665890369139544068-3A6Y
53. High dose intravenous immunoglobulin in treatment of patients with Covid-19 [11 May 2020] https://www.dhirubhai.net/posts/marcinkopka_high-dose-intravenous-immunoglobulin-as-a-activity-6665519916273147904-GeMz
54. Cardiac injury in hospitalized patients with COVID-19 [8 May 2020] https://www.dhirubhai.net/posts/marcinkopka_association-of-cardiac-injury-with-mortality-activity-6664425785853526016-aG41
55. Headaches Associated With Personal Protective Equipment [7 May 2020] https://www.dhirubhai.net/posts/marcinkopka_headaches-associated-with-personal-protective-activity-6664059669847261184-HRYX
56. Covid-19 outbreak and out-of-hospital cardiac arrest in Italy [6 May 2020] https://www.dhirubhai.net/posts/marcinkopka_out-of-hospital-cardiac-arrest-during-the-activity-6663705908075339776-mC5P
57. Remdesivir in adults with severe COVID-19 in China [5 May 2020] https://www.dhirubhai.net/posts/marcinkopka_remdesivir-in-adults-with-severe-covid-19-activity-6663336006906970112-U8yB
58. Diabetes mellitus is associated with increased mortality in COVID-19?[4 May 2020] https://www.dhirubhai.net/posts/marcinkopka_diabetes-mellitus-is-associated-with-increased-activity-6662986816628510720-hv0w
59. FDA authorizes remdesivir for emergency use in COVID-19 patients [2 May 2020] https://www.dhirubhai.net/posts/marcinkopka_fda-authorizes-experimental-drug-remdesivir-activity-6662263689720147968-MTDC
60. Gastrointestinal Manifestations in Patients with SARS-CoV-2 [1 May 2020] https://www.dhirubhai.net/posts/marcinkopka_high-prevalence-of-concurrent-gastrointestinal-activity-6661910699318497280-y5pR
61. Large-Vessel Stroke in the young patients with Covid-19 [30 April 2020] https://www.dhirubhai.net/posts/marcinkopka_large-vessel-stroke-as-a-presenting-feature-activity-6661539321432027136-eI2_
62. Incidence of thrombotic complications in patients with COVID-19 [29 April 2020] https://linkinghub.elsevier.com/retrieve/pii/S0049-3848(20)30120-1
63. Acute Cerebrovascular Disease in patients with COVID-19 [28 April 2020] https://www.dhirubhai.net/posts/marcinkopka_acute-cerebrovascular-disease-following-covid-activity-6660821402540617728-Plms
64. Guillain–Barré syndrome in patients infected with SARS-CoV-2. [27 April 2020] https://www.dhirubhai.net/posts/marcinkopka_guillainbarr%C3%A9-syndrome-associated-with-sars-cov-activity-6660456756491100160-rn1Z
65. A case of Tako-tsubo Cardiomyopathy elicted by anxiety related to COVID-19 pandemic [24 April 2020] https://www.dhirubhai.net/posts/marcinkopka_validate-user-activity-6659371577261477889-8G_J
66. Positive chest CT and negative RT-PCR testing in patients with Covid-19 [23 April 2020] https://www.dhirubhai.net/posts/marcinkopka_chest-ct-for-typical-2019-ncov-pneumonia-activity-6659016277517975552-kqnT
67. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia [22 April 2020] https://www.dhirubhai.net/posts/marcinkopka_pdf-use-of-corticosteroids-in-coronavirus-activity-6658639784065417216-7Dcb
68. Psychological impact of quarantine [17 April 2020] https://www.dhirubhai.net/posts/marcinkopka_the-psychological-impact-of-quarantine-and-activity-6656833040083361792-O4hM
69. Neurologic symptoms in patients with coronavirus disease 2019 [16 April 2020] https://www.dhirubhai.net/posts/marcinkopka_neurologic-manifestations-of-hospitalized-activity-6656495909972652032-htDa
70. Asymptomatic pregnant women patients positive for SARS-CoV-2 [15 April 2020] https://www.dhirubhai.net/posts/marcinkopka_universal-screening-for-sars-cov-2-in-women-activity-6656097426228813824-30ZL
71. The review the pathogen, clinical features, diagnosis, and treatment of COVID‐19 [14 April 2020] https://www.dhirubhai.net/posts/marcinkopka_coronavirus-disease-2019-what-we-know-activity-6655536250906259456-sFkG
72. The patients with Covid-19 complained of olfactory or taste disorders [12 April 2020] https://www.dhirubhai.net/posts/marcinkopka_self-reported-olfactory-and-taste-disorders-activity-6654708154548408320-S5Zf
73. Ivermectin may be useful in treating patients with Covid-19 [11 April 2020] https://www.dhirubhai.net/posts/marcinkopka_the-fda-approved-drug-ivermectin-inhibits-activity-6653764977314279424-bgFY
74. This first case of COVID-19–associated acute necrotizing hemorrhagic encephalopathy [10 April 2020] https://www.dhirubhai.net/posts/marcinkopka_covid-19associated-acute-hemorrhagic-necrotizing-activity-6652525822148132864-IZ6O
75. Covid-19 cases have been described in children [10 April 2020] https://www.dhirubhai.net/posts/marcinkopka_covid19-children-china-activity-6652291104672624640-TPQ9
76. The reasons for admission patients with Covid-19 to the ICU [10 April 2020] https://www.dhirubhai.net/posts/marcinkopka_covid-19-in-critically-ill-patients-in-the-activity-6652146536048271362-Mmqc

#CVD #cerebrovascular #Guillain #Barré #Tako #tsubo #cardiomiopathy #RT-PCR #Corticosteroids #psychological #neurologic #pregnant #olfactory #taste?#ivermectin #encephalopathy #children #ICU #thrombotic #complications?#stoke #gastrology #diabetes #hypertension #cardiac #arrest #headache #cardiac #immunoglobulin #tocilizumab #kawasaki #kidney #chronic #obstructive #pulmonary #disease #epilepsy #seizures #children #heart #failure #multisystem #inflammatory #syndrome?#MRI #asthma #status #epilepticus #subacute #thyroiditis?#dexamethasone #vaccine #pregnancy #solidarity #cerebral #venous #trombosis